Pharmabiz

Lipocine's PPD phase 3 study oral brexanolone hits 80% enrollment milestone

Lipocine's PPD phase 3 study oral brexanolone hits 80% enrollment milestone: Salt Lake City Wednesday, December 17, 2025, 18:00 Hrs [IST] Lipocine Inc., a biopharmaceutical compan ...
Pharmabiz

Arth by Emcure and Jai Vakeel Foundation host event to honour and support neurodivergent community

Arth by Emcure and Jai Vakeel Foundation host event to honour and support neurodivergent community: Our Bureau, Mumbai Wednesday, December 17, 2025, 17:20 Hrs [IST] Arth by Emcure ...
Pharmabiz

Lindus Health and Quotient Sciences partner to speed up drug development from first-in-human to pivotal trials

Lindus Health and Quotient Sciences partner to speed up drug development from first-in-human to pivotal trials: Boston Wednesday, December 17, 2025, 17:00 Hrs [IST] Lindus Health, ...
Pharmabiz

Pharma industry urged to overcome dependence to become self-reliant

Pharma industry urged to overcome dependence to become self-reliant: Shardul Nautiyal, Mumbai Wednesday, December 17, 2025, 16:50 Hrs [IST] India is star pharmacy to the world and ...
Pharmabiz

Utah Cancer Specialists partners with Canopy for remote therapeutic monitoring and Enterprise AI

Utah Cancer Specialists partners with Canopy for remote therapeutic monitoring and Enterprise AI: New York Wednesday, December 17, 2025, 16:00 Hrs [IST] Canopy, the leader in Ente ...
Pharmabiz

US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer

US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer: Cambridge, UK Wednesday, ...
Pharmabiz

Global Cancer Care expands access to credible cancer care for the masses

Global Cancer Care expands access to credible cancer care for the masses: Our Bureau, Mumbai Wednesday, December 17, 2025, 14:50 Hrs [IST] Global Cancer Care (GCC), a patient-firs ...
Pharmabiz

EMA committee recommends marketing approval for Lupin’s biosimilar ranibizumab

EMA committee recommends marketing approval for Lupin’s biosimilar ranibizumab: Our Bureau, Mumbai Wednesday, December 17, 2025, 14:40 Hrs [IST] Global pharma major Lupin Limite ...
Pharmabiz

Litemed backed CURAPOD gets CDSCO nod, a wearable class II device for musculoskeletal pain

Litemed backed CURAPOD gets CDSCO nod, a wearable class II device for musculoskeletal pain: Our Bureau, Bengaluru Wednesday, December 17, 2025, 14:30 Hrs [IST] CURAPOD, a Made-in- ...
Pharmabiz

Agilent Technologies opens India Refurbishment Center to advance sustainable science and affordable innovation

Agilent Technologies opens India Refurbishment Center to advance sustainable science and affordable innovation: Our Bureau, ...
Pharmabiz

US FDA grants 510(k) marketing clearance to Zephyrus Innovations’ VaporShield CSTD

US FDA grants 510(k) marketing clearance to Zephyrus Innovations’ VaporShield CSTD: Vancouver, BC Wednesday, December 17, 2025, 14:00 Hrs [IST] Zephyrus Innovations (Zephyrus), ...
Pharmabiz

Decode Age raises Rs. 14.48 crore in Pre Series A funding to advance longevity science and gut microbiome research

Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs. 14.48 crore in its Pre Series A funding round led by Dr Krishna ...